Octet application "COVID-19 Research"
We support researchers worldwide in the study and development of treatments and vaccines for SARS-CoV-2 through the Octet platform.
In January 2020, the genomic sequence of COVID-19 was released, leading to many papers that brought breakthroughs related to the biology, vaccines, and therapeutic development of coronaviruses, featuring data from the Octet system for analyzing biomolecular interactions. The document "Advancing development of coronavirus vaccine and therapeutics," which can be downloaded from the catalog below, presents research papers that elucidate the binding kinetics and affinity, neutralization, cross-blocking, and potency of COVID-19 virus particles using the Octet system. ■ Rapidly screen and select optimal vaccine and therapeutic candidates ■ Ensure research progresses with the best candidates determined based on data *For more details, please refer to the PDF document or feel free to contact us. 【Contact Information】 Sartorius Japan K.K. BioAnalytics Tel: 03-6478-5200 E-mail: ForteBioJP@Sartorius.com
basic information
**Application** ■ Insights into COVID-19 Binding Epitopes (Flyer) This showcases a case where the binding mechanism of the virus was elucidated using the Octet system. ■ Rapid and High-Precision Potency Assay for Influenza Vaccines (Application Note 20) The Octet platform measures the binding of vaccines/antigens to antibodies with high throughput, accuracy, and reproducibility, providing the process development group with a robust and user-friendly measurement method as an alternative to the SRID method.
Price range
Delivery Time
Applications/Examples of results
catalog（1）
Download All Catalogs
News about this product（2）
-
[New Product] Expandable Label-Free Real-Time Biomolecular Interaction Analysis System Octet R Series
Zaltrius has launched the Octet R series, a modular label-free real-time biomolecular interaction analysis system. It can be upgraded to meet future throughput demands, which helps to reduce initial costs. The Octet series employs a bio-layer interferometry method that does not require microfluidics, making maintenance easy, improving lab productivity, reducing costs, and shortening experimental timelines.
-
ForteBio On-Demand Webinar "Online Seminar on Promoting Research and Development for Treatments and Vaccine Development for COVID-19 Using Octet"
The World Health Organization (WHO) recognized on March 11, 2020, that the novel coronavirus (COVID-19) infection had reached a pandemic level. Currently, there is a demand for the acceleration of research on treatments and vaccine development for this infection. To expedite the development of therapeutics and vaccines, advanced analytical techniques are crucial for rapid screening of many candidates and for determining the most promising candidates. The Octet system enables real-time assays of biomolecular interactions using BLI technology and allows for high-throughput screening and evaluation of candidates through simultaneous measurement of multiple samples. As a result, data from the Octet system has been featured in many papers that bring breakthroughs related to the biological research of COVID-19 and vaccine and therapeutic development. ■ Ended (2020/10/20) 【Update Information】 If you wish to view the webinar, please fill in your customer information from the "Details & Application" link below. After completing your application, an On-Demand viewing link will be displayed on the screen. The webinar presentation slides can be downloaded from the related catalog below.
